(19)
(11) EP 4 486 459 A1

(12)

(43) Date of publication:
08.01.2025 Bulletin 2025/02

(21) Application number: 23713559.5

(22) Date of filing: 02.03.2023
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
A61K 39/395(2006.01)
C07K 16/44(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/44; C07K 2317/56; A61K 2039/505; A61P 35/00; C07K 2317/92; C07K 2317/24
(86) International application number:
PCT/US2023/063605
(87) International publication number:
WO 2023/168352 (07.09.2023 Gazette 2023/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 03.03.2022 US 202263316338 P

(71) Applicants:
  • Yale University
    New Haven, CT 06405 (US)
  • Gennao Bio, Inc.
    Pennington, NJ 08534 (US)

(72) Inventors:
  • QUIJANO, Elias
    New Haven, CT 06510 (US)
  • GLAZER, Peter
    New Haven, CT 06510 (US)
  • SQUINTO, Stephen
    New York, NY 10021 (US)
  • LUDWIG, Dale
    Pennington, NJ 08534 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) HUMANIZED 3E10 ANTIBODIES, VARIANTS, AND ANTIGEN BINDING FRAGMENTS THEREOF